A lesion’s type and location, and the number of muscles that a needle has to pierce to reach it, rather than the number of procedures, determine the level and duration of pain after radiofrequency ablation of osteoid osteomas, according to Mayo researchers.
More »A national registry for thermal ablation treatment for breast cancer is under consideration by the FDA. The agency opened a six-month public comment period this week on the proposed registry, which would compile information on all thermal ablation devices and therapies for small carcinomas.
More »CT-guided radiofrequency ablation offers long-term pain reduction in patients with osteoid osteoma, making it a viable alternative to open surgery, according to researchers from Seoul.
More »Results from two clinical trials demonstrate that cryoablation of renal cell carcinomas is effective at least a year after treatment in nearly all patients with lesions 4 cm or smaller. The studies suggest that cryotherapy could serve as an alternative to surgery.
More »Evidence from the largest study of its kind to date suggests that percutaneous CT-guided radiofrequency ablation is a safe and effective alternative to open surgery in selected cases of chondroblastomas, according to New York University researchers.
More »Ablation using high-intensity focused ultrasound can effectively control some types of localized prostate cancer for five years or longer, according to a study by German researchers.
More »
